<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	
	xmlns:georss="http://www.georss.org/georss"
	xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
	>

<channel>
	<title>Saxenda &#8211; Fat Weight Loss Canada</title>
	<atom:link href="https://fatweightloss.ca/tag/saxenda/feed/" rel="self" type="application/rss+xml" />
	<link>https://fatweightloss.ca</link>
	<description>&#124; FatWeightLoss.ca</description>
	<lastBuildDate>Mon, 08 Sep 2025 07:51:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>

<image>
	<url>https://fatweightloss.ca/wp-content/uploads/2024/06/cropped-Untitled-2024-06-20T105818.185-32x32.png</url>
	<title>Saxenda &#8211; Fat Weight Loss Canada</title>
	<link>https://fatweightloss.ca</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">234127269</site>	<item>
		<title>Who makes Saxenda?</title>
		<link>https://fatweightloss.ca/2025/09/08/who-makes-saxenda/</link>
					<comments>https://fatweightloss.ca/2025/09/08/who-makes-saxenda/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 08 Sep 2025 07:51:21 +0000</pubDate>
				<category><![CDATA[drugs]]></category>
		<category><![CDATA[Saxenda]]></category>
		<guid isPermaLink="false">https://fatweightloss.ca/?p=428</guid>

					<description><![CDATA[When you ask “Who makes Saxenda?”, the answer depends on whether you&#8217;re referring to the original drug or the generic version: 1. The Branded Drug – Saxenda 2. The Generic Version (Newly Approved in the U.S.) Summary Table Drug Manufacturer Branded Saxenda® Novo Nordisk Generic liraglutide (Saxenda equivalent) Teva Pharmaceuticals (in the U.S., as of [...]]]></description>
										<content:encoded><![CDATA[


<p>When you ask <strong>“Who makes Saxenda?”</strong>, the answer depends on whether you&#8217;re referring to the <strong>original drug</strong> or the <strong>generic version</strong>:</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h3 class="wp-block-heading">1. The Branded Drug – <strong>Saxenda</strong></h3>



<ul class="wp-block-list">
<li><strong>Manufacturer:</strong> The original <strong>Saxenda®</strong> (containing liraglutide) is developed, manufactured, and marketed by <strong>Novo Nordisk</strong>, a Danish multinational pharmaceutical company. (<a href="https://www.mims.com/thailand/drug/info/saxenda/presentation-and-price?utm_source=chatgpt.com">MIMS</a>, <a href="https://www.clinicaltrialsarena.com/marketdata/saxenda-liraglutide-obesity/?utm_source=chatgpt.com">Clinical Trials Arena</a>, <a href="https://en.wikipedia.org/wiki/Novo_Nordisk?utm_source=chatgpt.com">Wikipedia</a>)</li>



<li>Data from MIMS Thailand also confirms Novo Nordisk’s role as the manufacturer for Saxenda. (<a href="https://www.mims.com/thailand/drug/info/saxenda/presentation-and-price?utm_source=chatgpt.com">MIMS</a>)</li>
</ul>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h3 class="wp-block-heading">2. The Generic Version (Newly Approved in the U.S.)</h3>



<ul class="wp-block-list">
<li>In <strong>August 2025</strong>, the <strong>U.S. Food and Drug Administration (FDA)</strong> approved the <strong>first generic version of Saxenda (liraglutide injection)</strong>. This generic is developed and launched by <strong>Teva Pharmaceuticals</strong>. (<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-teva-pharmaceuticals-generic-obesity-drug-2025-08-28/?utm_source=chatgpt.com">Reuters</a>, <a href="https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/Teva-Announces-FDA-Approval-and-Launch-of-Generic-Saxenda-liraglutide-injection--First-Generic-GLP-1-Indicated-for-Weight-Loss/default.aspx?utm_source=chatgpt.com">ir.tevapharm.com</a>, <a href="https://www.biospace.com/fda/teva-brings-first-glp-1-generic-for-obesity-targets-novos-saxenda?utm_source=chatgpt.com">BioSpace</a>, <a href="https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity?utm_source=chatgpt.com">Fierce Pharma</a>)</li>



<li>Teva is now the first to offer a generic GLP‑1 agonist specifically indicated for weight loss in the U.S. (<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-teva-pharmaceuticals-generic-obesity-drug-2025-08-28/?utm_source=chatgpt.com">Reuters</a>, <a href="https://www.investors.com/news/technology/teva-pharmaceutical-generic-weight-loss-drug/?utm_source=chatgpt.com">Investors.com</a>, <a href="https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/Teva-Announces-FDA-Approval-and-Launch-of-Generic-Saxenda-liraglutide-injection--First-Generic-GLP-1-Indicated-for-Weight-Loss/default.aspx?utm_source=chatgpt.com">ir.tevapharm.com</a>, <a href="https://www.pharmaceutical-technology.com/news/teva-saxenda-generic-fda-approval-launch/?utm_source=chatgpt.com">Pharmaceutical Technology</a>, <a href="https://www.biospace.com/fda/teva-brings-first-glp-1-generic-for-obesity-targets-novos-saxenda?utm_source=chatgpt.com">BioSpace</a>)</li>
</ul>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h3 class="wp-block-heading">Summary Table</h3>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Drug</th><th>Manufacturer</th></tr></thead><tbody><tr><td>Branded <strong>Saxenda®</strong></td><td><strong>Novo Nordisk</strong></td></tr><tr><td>Generic <strong>liraglutide (Saxenda equivalent)</strong></td><td><strong>Teva Pharmaceuticals</strong> (in the U.S., as of August 2025)</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p>So in short:</p>



<ul class="wp-block-list">
<li><strong>Novo Nordisk</strong> originally manufactures and markets Saxenda under its brand.</li>



<li>As of <strong>August 2025</strong>, <strong>Teva Pharmaceuticals</strong> holds the FDA-approved generic version of Saxenda in the U.S.</li>
</ul>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p>If you&#8217;re interested, I can also share more context on Saxenda’s approvals, its global availability, or how the market for generic weight-loss drugs is evolving.</p>



<ul class="wp-block-list"></ul>



<p></p>
]]></content:encoded>
					
					<wfw:commentRss>https://fatweightloss.ca/2025/09/08/who-makes-saxenda/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">428</post-id>	</item>
		<item>
		<title>Comparing Bupropion/naltrexone Contrave to a GLP-1 like Wegovy or Saxenda?</title>
		<link>https://fatweightloss.ca/2025/09/08/comparing-contrave-to-a-glp-1-like-wegovy-or-saxenda/</link>
					<comments>https://fatweightloss.ca/2025/09/08/comparing-contrave-to-a-glp-1-like-wegovy-or-saxenda/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Mon, 08 Sep 2025 07:21:36 +0000</pubDate>
				<category><![CDATA[drugs]]></category>
		<category><![CDATA[Bupropion/naltrexone]]></category>
		<category><![CDATA[Contrave]]></category>
		<category><![CDATA[Saxenda]]></category>
		<category><![CDATA[Wegovy]]></category>
		<guid isPermaLink="false">https://fatweightloss.ca/?p=399</guid>

					<description><![CDATA[Comparing Contrave to a GLP-1 like Wegovy or Saxenda? Absolutely — here&#8217;s a clear side-by-side comparison of Contrave vs. GLP-1 drugs like Wegovy (semaglutide) and Saxenda (liraglutide) to help you understand how they differ: ⚖️ Contrave vs. GLP-1s (Wegovy &#38; Saxenda) Feature Contrave Wegovy (Semaglutide) Saxenda (Liraglutide) Drug Class Bupropion (antidepressant) + Naltrexone (opioid blocker) [...]]]></description>
										<content:encoded><![CDATA[


<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="1024" height="576" src="https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-1024x576.png" alt="" class="wp-image-406" srcset="https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-1024x576.png 1024w, https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-300x169.png 300w, https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-768x432.png 768w, https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-1536x864.png 1536w, https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-1320x743.png 1320w, https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills-510x287.png 510w, https://fatweightloss.ca/wp-content/uploads/2025/09/comparing-fat-weight-loss-pills.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p><strong>Comparing Contrave to a GLP-1 like Wegovy or Saxenda?</strong></p>



<p>Absolutely — here&#8217;s a clear <strong>side-by-side comparison</strong> of <strong>Contrave</strong> vs. <strong>GLP-1 drugs</strong> like <strong>Wegovy (semaglutide)</strong> and <strong>Saxenda (liraglutide)</strong> to help you understand how they differ:</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/2696.png" alt="⚖" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Contrave vs. GLP-1s (Wegovy &amp; Saxenda)</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Feature</th><th><strong>Contrave</strong></th><th><strong>Wegovy</strong> (Semaglutide)</th><th><strong>Saxenda</strong> (Liraglutide)</th></tr></thead><tbody><tr><td><strong>Drug Class</strong></td><td>Bupropion (antidepressant) + Naltrexone (opioid blocker)</td><td>GLP-1 receptor agonist</td><td>GLP-1 receptor agonist</td></tr><tr><td><strong>Delivery</strong></td><td>Oral pill (2x/day)</td><td>Injection (1x/week)</td><td>Injection (1x/day)</td></tr><tr><td><strong>Average Weight Loss</strong></td><td>~5–9% of body weight</td><td>~15% (can reach 20%+)</td><td>~8%</td></tr><tr><td><strong>Time to Effect</strong></td><td>Slower onset (~weeks)</td><td>Starts within weeks, peaks over months</td><td>Similar to Wegovy but slightly less potent</td></tr><tr><td><strong>FDA Approved For</strong></td><td>Weight loss</td><td>Weight loss + type 2 diabetes (Ozempic)</td><td>Weight loss + type 2 diabetes (Victoza)</td></tr><tr><td><strong>Appetite/Craving Control</strong></td><td>Strong focus on <strong>cravings</strong></td><td>Strong appetite suppression &amp; fullness</td><td>Moderate appetite suppression</td></tr><tr><td><strong>Insurance Coverage</strong></td><td>Moderate</td><td>Increasingly common, but still limited</td><td>Similar to Wegovy</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Advantages of Each</strong></h2>



<h3 class="wp-block-heading"><strong>Contrave</strong></h3>



<ul class="wp-block-list">
<li>Oral (no needles)</li>



<li>Helps with <strong>emotional eating</strong> or <strong>cravings</strong></li>



<li>May improve <strong>mood</strong> (bupropion component)</li>



<li>May be better tolerated by those who can’t handle GLP-1 side effects</li>
</ul>



<h3 class="wp-block-heading"><strong>Wegovy</strong></h3>



<ul class="wp-block-list">
<li>Most <strong>effective</strong> FDA-approved weight loss drug (20%+ for some)</li>



<li>Weekly injection is more convenient than daily meds</li>



<li>Better <strong>metabolic benefits</strong> (e.g., blood sugar, cholesterol)</li>
</ul>



<h3 class="wp-block-heading"><strong>Saxenda</strong></h3>



<ul class="wp-block-list">
<li>Daily injection (some prefer routine over once-weekly)</li>



<li>Longest track record of GLP-1 safety for weight loss</li>



<li>More affordable than Wegovy in some cases</li>
</ul>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/26a0.png" alt="⚠" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Side Effect Comparison</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th><strong>Side Effect</strong></th><th><strong>Contrave</strong></th><th><strong>Wegovy/Saxenda</strong></th></tr></thead><tbody><tr><td><strong>Nausea</strong></td><td>Common (~30%)</td><td>Very common (~40–50%)</td></tr><tr><td><strong>Vomiting/Diarrhea</strong></td><td>Less common</td><td>Common (esp. at higher doses)</td></tr><tr><td><strong>Headache/Dizziness</strong></td><td>Moderate</td><td>Sometimes</td></tr><tr><td><strong>Insomnia/Anxiety</strong></td><td>More likely with Contrave</td><td>Rare with GLP-1s</td></tr><tr><td><strong>Craving Control</strong></td><td>Strong</td><td>Moderate (mainly reduces hunger)</td></tr><tr><td><strong>Injection Site Issues</strong></td><td>None</td><td>Redness, discomfort possible</td></tr><tr><td><strong>Seizure Risk</strong></td><td>Yes (bupropion lowers threshold)</td><td>No</td></tr><tr><td><strong>Pancreatitis/Gallstones</strong></td><td>Rare</td><td>Rare but possible</td></tr><tr><td><strong>Suicidal Thoughts</strong></td><td>Warning for Contrave</td><td>No black box warning for GLP-1s</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/274c.png" alt="❌" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Who Should Avoid Each Drug?</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th><strong>Medication</strong></th><th><strong>Avoid If You Have…</strong></th></tr></thead><tbody><tr><td><strong>Contrave</strong></td><td>&#8211; Seizure history- Eating disorders- Uncontrolled hypertension- Using opioids</td></tr><tr><td><strong>Wegovy</strong></td><td>&#8211; History of pancreatitis- Medullary thyroid cancer or MEN 2- Severe GI disease</td></tr><tr><td><strong>Saxenda</strong></td><td>&#8211; Same as Wegovy; also caution in kidney disease</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/1f9ed.png" alt="🧭" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Which Should You Choose?</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th><strong>If You Want…</strong></th><th><strong>Best Option</strong></th></tr></thead><tbody><tr><td>Highest weight loss potential</td><td><strong>Wegovy</strong></td></tr><tr><td>Oral medication, no injections</td><td><strong>Contrave</strong></td></tr><tr><td>Help with emotional/binge eating</td><td><strong>Contrave</strong></td></tr><tr><td>Once-a-week convenience</td><td><strong>Wegovy</strong></td></tr><tr><td>Tried-and-true daily GLP-1</td><td><strong>Saxenda</strong></td></tr><tr><td>Can&#8217;t tolerate Wegovy or semaglutide</td><td><strong>Saxenda or Contrave</strong></td></tr><tr><td>Can&#8217;t use GLP-1s due to thyroid risk</td><td><strong>Contrave</strong></td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><img src="https://s.w.org/images/core/emoji/16.0.1/72x72/1f4a1.png" alt="💡" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Final Thoughts</h2>



<ul class="wp-block-list">
<li><strong>Contrave</strong> is <strong>less potent</strong> than GLP-1s but may be ideal for those with <strong>emotional eating</strong>, or who prefer <strong>oral meds</strong>.</li>



<li><strong>Wegovy</strong> is the <strong>most effective FDA-approved</strong> weight loss drug on the market.</li>



<li><strong>Saxenda</strong> offers a middle ground — daily injections, with proven safety and decent effectiveness.</li>
</ul>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p>Would you like help choosing based on <strong>your specific medical conditions, preferences, or insurance access</strong>?</p>
]]></content:encoded>
					
					<wfw:commentRss>https://fatweightloss.ca/2025/09/08/comparing-contrave-to-a-glp-1-like-wegovy-or-saxenda/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">399</post-id>	</item>
	</channel>
</rss>
